Back to Search

DAVID REARDON, MD

MD

Anatomic Pathology & Clinical Pathology Physician

NPI: 1871572651Individual

Specialties, Licenses & Credentials

Anatomic Pathology & Clinical Pathology PhysicianPrimary

Pathology — Anatomic Pathology & Clinical Pathology

Code: 207ZP0102X

ME50460(FL)
Blood Banking & Transfusion Medicine Physician

Pathology — Blood Banking & Transfusion Medicine

Code: 207ZB0001X

ME50460(FL)
Chemical Pathology Physician

Pathology — Chemical Pathology

Code: 207ZP0104X

ME50460(FL)

Research & Publications (20)

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
PMID 19562254·J Neurooncol·2010
3-trial
Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
PMID 19514083·Cancer·2009
8-other
Will integrin inhibitors have proangiogenic effects in the clinic?
PMID 19584855·Nat Med·2009
7-preclinical
Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma.
PMID 19248046·Cancer·2009
3-trial
Cancer: The nuances of therapy.
PMID 19295595·Nature·2009
7-preclinical
Targeting multiple kinases in glioblastoma multiforme.
PMID 19243279·Expert Opin Investig Drugs·2009
6-review
IDH1 and IDH2 mutations in gliomas.
PMID 19228619·N Engl J Med·2009
8-other
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
PMID 19533023·J Neurooncol·2009
3-trial
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
PMID 19402172·Cancer·2009
3-trial
Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing.
PMID 19212703·J Neurooncol·2009
8-other
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.
PMID 19204199·J Clin Oncol·2009
3-trial
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme.
PMID 19188181·Clin Cancer Res·2009
3-trial
Computerized assessment of vessel morphological changes during treatment of glioblastoma multiforme: report of a case imaged serially by MRA over four years.
PMID 19103295·Neuroimage·2009
5-case
Experience with irinotecan for the treatment of malignant glioma.
PMID 18784279·Neuro Oncol·2009
6-review
Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients.
PMID 19415455·J Neurooncol·2009
3-trial
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.
PMID 19289491·Neuro Oncol·2009
3-trial
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.
PMID 18981465·J Clin Oncol·2008
3-trial
Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas.
PMID 18981004·Clin Cancer Res·2008
3-trial
Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma.
PMID 18755919·Neuro Oncol·2008
8-other
Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme.
PMID 18616418·Expert Opin Investig Drugs·2008
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1620 MEDICAL LN, SUITE 100
FT MYERS, FL 33907

Location

Practice Location

1620 MEDICAL LN, FT MYERS, FL
(239) 275-1164

Quick Facts

NPI
1871572651
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
3
Locations
1
Publications
20

Are you this provider?

Claim Your Profile